AI Article Synopsis

  • A study investigated the presence of intraepithelial lymphocyte (IEL) infiltration in patients with potential autoimmune gastritis (AIG) who had positive anti-parietal cell antibodies but no gastric atrophy.
  • Nine patients who developed overt AIG were analyzed for deep and superficial CD3+ IEL counts, revealing significantly higher deep IEL counts compared to healthy controls and those with active H. pylori gastritis.
  • Results suggest that increased deep CD3+ IEL infiltration could serve as a marker for potential AIG, indicating the need for further studies with more patients to confirm these findings.

Article Abstract

Pathological correlates of potential autoimmune gastritis (AIG), defined by anti-parietal cell antibody (PCA) positivity in the absence of gastric atrophy, have never been described. We herein aimed to assess intraepithelial lymphocyte (IEL) infiltration in gastric corpus of AIG patients. From 2000 to 2021, among 53 potential AIG patients, we focused on nine (median age 61 years, IQR 53-82; four females) who subsequently developed overt AIG. IEL infiltration of the oxyntic mucosa was assessed before and after developing overt AIG by measuring deep and superficial CD3+ IEL. AIG patients with different degrees of corpus atrophy, healthy controls (HC), active H. pylori gastritis, celiac disease (CD), and Hashimoto's thyroiditis patients were included as controls. Of note, deep, but not superficial, CD3+ IEL count was higher (p<0.001) in potential AIG compared to HC and H. pylori gastritis. Deep CD3+ IEL infiltration did not change before or after the evolution into atrophy (median 9.6, IQR 8.8-12.4, vs 11.3, IQR 9.4-12.9). No difference was found in deep CD3+ IEL infiltration among potential, mild, and severe AIG, and compared to Hashimoto's thyroiditis or CD. A deep CD3+ IEL cut-off of >7/100 epithelial cells allowed discrimination of any AIG stage and severity (AUC=0.842). We conclude that an increased deep CD3+ IEL infiltration of the oxyntic mucosa could represent a marker of potential AIG. Prospective studies including a larger number of potential AIG patients are needed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114815PMC
http://dx.doi.org/10.3389/fimmu.2022.866167DOI Listing

Publication Analysis

Top Keywords

aig patients
12
oxyntic mucosa
8
autoimmune gastritis
8
iel infiltration
8
overt aig
8
deep superficial
8
superficial cd3+
8
cd3+ iel
8
aig
6
patients
5

Similar Publications

Background: The relationship between autoimmune gastritis (AIG) and gastric polyps (GPs) is not well understood.

Aim: To explore the clinical characteristics and risk factors of AIG with GPs in patients.

Methods: This double center retrospective study included 530 patients diagnosed with AIG from July 2019 to July 2023.

View Article and Find Full Text PDF

Objectives: We present a case series of patients with granulomatous myocarditis presenting as atrial arrhythmias accompanied by lymphadenopathy.

Background: Atrial myocarditis (AM) may be the cause of atrial fibrillation (AF) in patients without risk factors.

Methods: Patients with atrial fibrillation without risk factors underwent 18F-Fluorodeoxyglucose positron emission tomography (18F-FDG-PET).

View Article and Find Full Text PDF

The relationship between autoimmune gastritis (AIG) and Helicobacter pylori (H. pylori) gastritis remains unclear, particularly whether there is any interaction. Herein, we report a case of early-stage AIG diagnosed in an elderly patient with highly active H.

View Article and Find Full Text PDF

The integration of conventional omics data such as genomics and transcriptomics data into artificial intelligence models has advanced significantly in recent years; however, their low applicability in clinical contexts, due to the high complexity of models, has been limited in their direct use inpatients. We integrated classic omics, including DNA mutation and RNA gene expression, added a novel focus on promising omics methods based on A>I(G) RNA editing, and developed a drug response prediction model. We analyzed 104 patients from the Breast Cancer Genome-Guided Therapy Study (NCT02022202).

View Article and Find Full Text PDF

Gastrointestinal (GI) symptoms occur frequently in pregnant women, resulting in poor quality of life. These patients frequently require co-management with the obstetrician and a physician/GI specialist. The causation is complex and multifactorial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!